Article

Multiple factors determine residual refractive error

Attention to a host of preoperative and intraoperative factors can minimize the risk of residual refractive error after cataract surgery, but when a refractive surprise occurs, there are multiple variables to consider before deciding on intervention according to one expert.

According to national benchmarks, cataract surgeons should aim for the achieved refraction to be within 0.5 D of the target about 55% of the time and within 1.0 D in about 85% of cases.

Dr. Arbisser said that, in her hands and based on analysis of data for all comers, she well exceeds these targets with 85% of eyes achieving a refraction ±0.5 D of the target and 99.2% having a RRE <1.0 D.

Preventive strategies

"Although we cannot bill for this procedure, it may be worth obtaining an axial length measurement with [partial coherence interferometry] when patients present with early cataractous changes, even if surgery is not yet contemplated, just in case the patient does not return before the cataract becomes super dense," Dr. Arbisser said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
© 2025 MJH Life Sciences

All rights reserved.